Certain hydrolyzed formulas reduce the incidence of atopic dermatitis but not that of asthma: Three-year results of the German Infant Nutritional Intervention Study  Andrea von Berg, MD, Sibylle Koletzko, MD, Birgit Filipiak-Pittroff, MSc, Birgit Laubereau, MD, Armin Grübl, MD, Heinz-Erich Wichmann, PhD, MD, Carl-Peter Bauer, MD, Dietrich Reinhardt, MD, Dietrich Berdel, MD  Journal of Allergy and Clinical Immunology  Volume 119, Issue 3, Pages 718-725 (March 2007) DOI: 10.1016/j.jaci.2006.11.017 Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 GINI trial profile from birth to 3 years. PP analysis in children of the interventional arm at 4 month and 1 and 3 years. The ITT analysis (N = 1363) included the 191 early dropouts and all children of the interventional arm (N = 1172). The observational arm included all children who were exclusively breast-fed for 4 months (BF). Journal of Allergy and Clinical Immunology 2007 119, 718-725DOI: (10.1016/j.jaci.2006.11.017) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Crude cumulative incidence and period prevalence of AM (A, B) and of AD (C, D) in the 4 study groups during the first 3 years. Results of the per protocol analysis. Journal of Allergy and Clinical Immunology 2007 119, 718-725DOI: (10.1016/j.jaci.2006.11.017) Copyright © 2007 American Academy of Allergy, Asthma & Immunology Terms and Conditions